ArticleAging clinical and experimental research2025
The association between sarcopenic obesity and depression in middle-aged and elderly U.S. adults: insights from the NHANES study.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring the mediating roles of diet and physical activity in the association between different obesity phenotypes and risk of depression: A cox survival analysis approach.Comprehensive psychoneuroendocrinology · 2026Article
- Adverse outcomes of sarcopenic obesity in older adults: a scoping review.Frontiers in nutrition · 2026Review
Corrections and comments
- Commented on by
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to explore the association between sarcopenia, obesity, and sarcopenic obesity with depression in a middle-aged and elderly population in the United States.
methodsWe analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2006 and from 2011 to 2018, including 5155 participants aged 45 years and older. Obesity was defined by a body mass index (BMI) ≥ 30 or waist circumference (WC) ≥ 102 cm in men or ≥ 88 cm in women. Sarcopenia was assessed using dual-energy X-ray absorptiometry (DXA) to calculate appendicular skeletal muscle mass index (ASMI), with gender-specific cut-offs. Multivariate logistic regression models adjusted for various covariates were used to assess the associations.
resultsParticipants classified into the sarcopenia-only, obesity-only, and sarcopenic obesity groups exhibited multivariable-adjusted odds ratios (ORs) for depression of 1.35 (95% CI 0.60-2.18; P = 0.371), 1.37 (95% CI 1.03-1.82; P = 0.031), and 2.07 (95% CI 1.36-3.16; P < 0.001), respectively, compared to the robust group. Sensitivity analyses using alternative definitions of obesity and multiple imputation for missing data confirmed these findings. Subgroup analyses revealed that the association between sarcopenic obesity and depression was more pronounced in middle-aged women (aged ≤ 52 years).
conclusionThis study underscores the significant relationship between sarcopenic obesity and depression in a large U.S. middle-aged and elderly population. Interventions focusing on weight control and muscle mass enhancement through proper nutrition and physical activity may reduce depression incidence, thereby promoting healthy aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.